Retinoblastoma major review with updates on Middle East management protocols
Author(s) -
Ihab Saad Othman
Publication year - 2012
Publication title -
saudi journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.359
H-Index - 25
eISSN - 2542-6680
pISSN - 1319-4534
DOI - 10.1016/j.sjopt.2012.03.002
Subject(s) - retinoblastoma , enucleation , medicine , disease , presentation (obstetrics) , stage (stratigraphy) , pediatrics , intensive care medicine , surgery , pathology , paleontology , biochemistry , chemistry , biology , gene
Many advances in the field of management of retinoblastoma emerged in the past few years. Patterns of presentation of retinoblastoma in the Middle East region differ from Western community. The use of enucleation as a radical method of eradicating advanced disease is not easily accepted by patient's family. We still do see stage E, failed or resistant retinoblastoma and advanced extraocular disease ensues as a result of delayed enucleation decision. In this review, we discuss updates in management of retinoblastoma with its implication on patients in our part of the world. Identifying clinical and high risk characteristics is important prognostically and are discussed for further management of retinoblastoma cases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom